The Liver Meeting 2019-Assessing and Addressing Liver Fibrosis in the Allograft

Assessing and Addressing Liver Fibrosis in the Allograft

Video Transcription

Video Summary

The speaker discusses the assessment and staging of liver fibrosis in allografts, focusing on the impact of various factors on the development of fibrosis over time. They highlight the importance of monitoring children post-transplantation for signs of fibrosis progression, showcasing data from protocol biopsies performed at different intervals. The presentation emphasizes the role of autoantibodies and immunomodulatory pathways in graft hepatitis and fibrosis development. Insights from studies on different treatment regimens suggest limited impact on fibrosis progression. The speaker underscores the need for continued research to improve understanding and management of fibrosis in allograft recipients.

Asset Caption

Presenter: Deirdre A. Kelly

Keywords

liver fibrosis

allografts

assessment

children post-transplantation

autoantibodies

research